MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies magnetic resonance imaging (MRI) with gadoxetate disodium
in measuring tumors in patients with liver cancer. Diagnostic procedures, such as MRI with
gadoxetate disodium, may help find and diagnose liver cancer and find out how far the disease
has spread. It is not yet known whether MRI with gadoxetate disodium provides a more precise
measurement of liver tumors than standard computed tomography (CT).